Drug Information Association Logo

Continuing Education

ACPE

The Drug Information Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is designated for up to 22.5 contact hours or 2.25 continuing education units (CEU’s).

ACPE Credit Requests

DIA is required by the Accreditation Council for Pharmacy Education (ACPE) to report pharmacy-requested CEUs through the CPE Monitor system. All ACPE-certified activity credit requests need to be submitted through DIA’s My Transcript within 45-days post activity. Pharmacists will need to provide their National Association of Boards of Pharmacy (NABP) e-Profile ID and date of birth (MMDD) to ensure the data is submitted to the ACPE and NABP properly. If you need to obtain your NABP e-Profile, please visit www.cpemonitor.net.

ANCC

Corexcel is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Corexcel designates this activity for a maximum of 25.75 contact hours.

IACET

Drug Information Association has been accredited as an Authorized Provider by the International Association for Continuing Education and Training (IACET), 1760 Old Meadow Road, Suite 500, McLean, VA 22102; +1.703.506.3275.

As an IACET Authorized Provider, Drug Information Association offers CEUs for its programs that qualify under the ANSI/IACET Standard. Drug Information Association is authorized by IACET to offer up to 2.6 CEUs for this program. Participants must attend the entire program <core curriculum, tutorial, conference, if applicable> in order to be able to receive an IACET statement of credit. No partial credit will be awarded.

If you would like to receive a statement of credit, you must attend the conference, core curriculum, and/or tutorials, if applicable, scan your name badge at each session, core curriculum and/or tutorial you attend, and complete the on line credit request process through My Transcript. To access My Transcript, please go to www.diahome.org, select “Login to My DIA” and you will be prompted for your user ID and password. Select “My Transcript” (left side bar) and “Credit Request” to process your credit request. Participants will be able to download a statement of credit upon successful submission of the credit request. My Transcript will be available for credit requests on Wednesday, March 26, 2014.

Please Note: If you do not scan your badge at each session you attend, you will not be able to request continuing education credits for that portion of the program.

It is Drug Information Association policy that anyone in a position to control the content of a continuing education activity must disclose to the program audience (1) any real or apparent conflict(s) of interest related to the content of their presentation and/or the educational activity, and (2) discussions of unlabeled or unapproved uses of drugs or medical devices. Faculty disclosures will be included in the course materials.


CONTINUING EDUCATION CREDIT ALLOCATION

Core Curriculum: Pharmacy up to 7.25 contact hours or .725 CEUs; Nursing up to 7.25 contact hours; IACET .7 CEUs

Tutorial 1 – Medical Communications: Compliance in 2014: Pharmacy 3.25 contact hours or .325 CEUs; Nursing 3.25 contact hours; IACET .3 CEUs

Tutorial 2 – Interpreting and Reporting Descriptive Statistics, Confidence Intervals, and Hypothesis Tests: Nursing 3.25 contact hours; IACET .3 CEUs

Conference: Pharmacy up to 12 contact hours or 1.2 CEUs; Nursing up to 15.25 contact hours; IACET 1.5 CEUs


Pharmacy Credit Breakdown

Core Curriculum
Sessions 1 and 2
: 3.25 contact hours or .325 CEUs, 0286-0000-14-045-L04-P, Type of Activity: Application

Sessions 3 and 4: 4 contact hours or .4 CEUs, 0286-0000-14-046-L04-P, Type of Activity: Knowledge

Tutorial
Tutorial 1 – Medical Communications: Compliance in 2014: Pharmacy 3.25 contact hours or .325 CEUs, 0286-0000-14-047-L04-P, Type of Activity: Knowledge

Conference
Session 2E: Part I:  "Real World Data" What is it, How is it Being Used and How Does it Impact the MSL Role?: 1.5 contact hours or .15 CEUs, 0286-0000-14-048-L04-P, Type of Activity: Knowledge

Session 3A: Drug Information Compendia: Evaluating Drug Monograph Content, Impact on Patient Care and Understanding Transparency: 1.5 contact hours or .15 CEUs, 0286-0000-14-049-L04-P, Type of Activity: Knowledge

Session 3B: Technology in the Medical Information Contact Center: Innovation and Best Practices: 1.5 contact hours or .15 CEUs, 0286-0000-14-050-L04-P, Type of Activity: Knowledge

Session 3E: Part II: The Integration of Real World Data into Patient Care Management and the Industry: 1.5 contact hours or .15 CEUs, 0286-0000-14-051-L04-P, Type of Activity: Application

Session 4A: Hot Topics: Innovations in Medical Communications: 1.5 contact hours or .15 CEUs, 0286-0000-14-052-L04-P, Type of Activity: Knowledge

Session 4E: Technology Showcase- Using Technology to Strengthen the Customer Interface: 1.5 contact hours or .15 CEUs, 0286-0000-14-053-L04-P, Type of Activity: Application

Session 5D: Health Economics Outcome / Comparative Effectiveness Research: 1.5 contact hours or .15 CEUs, 0286-0000-14-054-L04-P, Type of Activity: Application

Session 6A-B: Voice of the Customer (VOC), How do you Measure it and What do you Do with it?: 1.5 contact hours or .15 CEUs, 0286-0000-14-055-L04-P, Type of Activity: Application

Session 7A-B: Disruptive Innovation in Medical Information: 1.5 contact hours or .15 CEUs, 0286-0000-14-056-L04-P, Type of Activity: Application

Session 7C-D: Ethics in Medical Writing: 1.5 contact hours or .15 CEUs, 0286-0000-14-057-L04-P, Type of Activity: Knowledge

Session 7E: Scope of MSL Proactive Engagements: 1.5 contact hours or .15 CEUs, 0286-0000-14-058-L04-P, Type of Activity: Knowledge

Session 8C: Safety Reporting: What Writers Need to Know: 1.5 contact hours or .15 CEUs, 0286-0000-14-059-L04-P, Type of Activity: Knowledge

Session 10A-B: Crystal Ball Management: Preparing for Expected and Unexpected Events: 1.5 contact hours or .15 CEUs, 0286-0000-14-060-L04-P, Type of Activity: Application

Session 10D: Publications in a Brave New World: 1.5 contact hours or .15 CEUs, 0286-0000-14-061-L04-P, Type of Activity: Knowledge

  • Tutorial 2: Interpreting and Reporting Descriptive Statistics, Confidence Intervals, and Hypothesis Tests
  • Welcome
  • Keynote Presentation
  • 2A-B: Sunshine Act and Implications to Medical Communications
  • 2C-D: Professionalism and Certification in Medical Writing
  • 3C-D: Always Keeping a Ball in the Air:  Project Management in Medical Writing
  • 4B: The 4 Cs of Quality Monitoring: Coaching, Compliance, Calibration, and Continuous Improvement
  • 4C: Lessons Learned from Preparing Responses to Post-Filing Regulatory Queries from Regional Health Authorities (FDA, CHMP, PMDA)
  • 4D: What’s up on the Hill?—What Medical Communications Professionals Need to Know (Sunshine Act and Corporate Integrity Agreement) – Roundtable Discussion
  • Buffet Lunch/Roundtable Discussions
  • Resident, Fellow, and Preceptor Development Session
  • Global MSL Functions
  • 5A: Adapting and Refining Technologies within Medical Information to Drive Innovation
  • 5B: What If?
  • 5C: Medical Writing Outsourcing Models
  • 5E: Win-Win Solutions and Best Practices – A Soft Skills Showcase
  • 6C: Strategic Review of Documents
  • 6D:  Global Publication Planning
  • 6E: Own Your Career
  • 8A-B: Podium Pearls
  • 8D: Best Practices in Publications
  • 8E: Unique Value: How to Differentiate and Measure
  • 9: Luncheon/Professional Poster Session
  • 10C: Global Developments in Clinical Trial Transparency and Their Impact on Clinical Trial Disclosure and Publication Writing
  • 10E: Building an MSL Team
  • 11: Closing Plenary and Closing Remarks


Disclosure Policy
It is Drug Information Association policy that anyone in a position to control the content of a continuing education activity must disclose to the program audience (1) any real or apparent conflict(s) of interest related to the content of their presentation and/or the educational activity, and (2) discussions of unlabeled or unapproved uses of drugs or medical devices. Faculty disclosures will be included in the course materials.

Disclaimer

Unless otherwise disclosed, the statements made by speakers represent their own opinions and not necessarily those of the organization they represent, or that of the Drug Information Association. Speakers, agenda, and CE information are subject to change without notice. Recording of any DIA educational material in any type of media, is prohibited without prior written consent from DIA.

View DIA’s Grievance Policy.

AMERICANS WITH DISABILITIES ACT (ADA)
Reasonable accommodations will be made available to persons with disabilities who attend an educational activity.  Contact the DIA office in writing at least 15 days prior to event to indicate your needs.
© 2014 DIA